[Latest] Global Induced Pluripotent Stem Cell iPSC Market Size/Share Worth USD 4.91 Billion by 2034 at a 10.25% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Fo...
Bioventus Inc. - Class A (BVS)
Company Research
Source: Latest
Stem Cells Market size & share revenue was valued at approximately USD 1.85 Billion in 2024 and is expected to reach USD 2.04 Billion in 2025 and is expected to reach around USD 4.91 Billion by 2034, at a CAGR of 10.25% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Aesculap, Bioventus, DePuy Synthes, Disc Dynamics, Exactech, Globus Medical, Insightec, Integra LifeSciences, K2M Group Holdings, Medtronic, NuVasive, Orthofix Medical, Spinal Elements, Stryker, Zimmer Biomet, and others. Austin, TX, USA, April 03, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “ Induced Pluripotent Stem Cell iPSC Market Size, Trends and Insights By Derived Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others), By Application (Drug Development, Tissue Engineering & Regenerative Medicine, Disease Modelling, Toxicology Research), By End-Use (Academic & Research Institutes, Pha
Show less
Read more
Impact Snapshot
Event Time:
BVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BVS alerts
High impacting Bioventus Inc. - Class A news events
Weekly update
A roundup of the hottest topics
BVS
News
- HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
- Bioventus: A New Start [Seeking Alpha]Seeking Alpha
- Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Bioventus to Present at the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- Bioventus (NASDAQ:BVS) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
BVS
Earnings
- 8/6/25 - Miss
BVS
Sec Filings
- 12/8/25 - Form 4
- 12/4/25 - Form 144
- 11/25/25 - Form 3
- BVS's page on the SEC website